文献速递脑血管病

脑淀粉样血管病影像标志与波士顿标准对溶栓结局的影响

Cerebral Amyloid Angiopathy Imaging Markers, Radiological Boston Criteria, and Thrombolysis Outcomes in Ischemic Stroke.
PubMed 文献 · Stroke · 2026-01-29

基于AcT试验1600例急性缺血性卒中患者中482例有可用MRI者,评估放射学波士顿CAA标准及其组成标志与静脉溶栓后出血风险和功能结局的关联。结果显示皮质表面铁沉积负荷与症状性ICH、任何ICH、出血严重程度、90天死亡和不良功能结局独立相关;符合波士顿标准1.0或1.5版增加任何ICH风险,而2.0版与出血结局无显著关联。

要点

  • 皮质表面铁沉积负荷每增加一个受累脑沟,症状性ICH风险显著升高(aOR 3.88)。
  • 符合放射学波士顿标准1.0或1.5版与任何ICH风险增加相关,2.0版无显著关联。
  • 皮质表面铁沉积负荷是权衡溶栓风险与获益时尤其相关的CAA标志。

核心结论

  • 在溶栓的急性缺血性卒中患者中,皮质表面铁沉积负荷与严重出血、残疾和死亡风险强烈且一致相关。
  • 符合放射学波士顿标准1.0或1.5版增加出血风险,但符合最新2.0版不增加。

研究设计与样本

  • 基于AcT试验(阿替普酶对比替奈普酶)的二次分析,纳入1600例患者中有适宜MRI的482例(平均年龄71岁,女性47.1%)。
  • 由盲法评估者记录脑叶微出血、皮质表面铁沉积、白质高信号多斑点征和半卵圆中心扩大的血管周围间隙,并按波士顿标准1.0、1.5和2.0版分类。
  • 采用多变量逻辑或有序回归,校正年龄、性别、基线卒中严重程度、糖尿病、高血压、发病至溶栓时间、溶栓药物和血管内治疗。

主要发现

  • 皮质表面铁沉积每增加一个受累脑沟,症状性ICH的aOR为3.88(95%CI 2.87-5.26),任何ICH的aOR为1.91(95%CI 1.22-2.98)。
  • 皮质表面铁沉积负荷增加与90天死亡风险升高(aOR 1.42,95%CI 1.18-1.71)和改良Rankin量表评分更差(调整后共同OR 1.74,95%CI 1.58-1.91)相关。
  • 皮质表面铁沉积负荷增加与优良功能恢复几率降低相关(aOR 0.70,95%CI 0.64-0.77)。
  • 符合波士顿标准1.0和1.5版 probable 增加任何ICH风险(aOR分别为2.57和2.39;95%CI分别为2.05-3.23和1.71-3.34)。
  • 符合波士顿标准1.5版 possible 与更差改良Rankin量表评分相关(调整后共同OR 2.34,95%CI 1.30-4.22);2.0版与任何出血结局无显著关联。

关键数值与推荐

  • 皮质表面铁沉积负荷每增加一个受累脑沟,症状性ICH风险aOR 3.88(95%CI 2.87-5.26)。
  • 符合放射学波士顿标准1.0版 probable 的任何ICH风险aOR 2.57(95%CI 2.05-3.23);1.5版 probable 的aOR 2.39(95%CI 1.71-3.34)。
  • 符合波士顿标准1.5版 possible 的改良Rankin量表评分更差,调整后共同OR 2.34(95%CI 1.30-4.22)。

临床怎么用

  • 对急性缺血性卒中拟溶栓患者,应评估MRI上的皮质表面铁沉积负荷以辅助权衡出血风险与获益。
  • 符合放射学波士顿标准1.0或1.5版提示任何ICH风险增加,但2.0版未显示显著关联,临床解读需注意标准版本差异。

局限性

  • 为AcT试验的二次分析,结果需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cerebral amyloid angiopathy (CAA) is thought to increase the risk of postthrombolytic intracranial bleeding, yet CAA neuroimaging markers and magnetic resonance imaging criteria have not been systematically evaluated in large acute stroke trials. We, therefore, examined the association of radiological Boston CAA criteria and their constituent markers with hemorrhagic risks and functional outcomes after intravenous thrombolysis in the AcT trial (Alteplase Compared to Tenecteplase). METHODS: Blinded raters recorded lobar cerebral microbleeds, cortical superficial siderosis, white matter hyperintensity multispot sign, and centrum semiovale enlarged perivascular spaces, and classified possible and probable CAA according to radiological Boston criteria iterations, versions 1.0, 1.5, and 2.0. Multivariable logistic or ordinal regressions, adjusted for age, sex, baseline stroke severity, diabetes, hypertension, onset-to-needle time, thrombolytic agent, and endovascular therapy, assessed associations of these features/criteria with safety end points: symptomatic intracerebral hemorrhage (ICH), any ICH, Heidelberg hemorrhage grade, 90-day mortality, and functional outcomes (modified Rankin Scale score of 0-1 and ordinal modified Rankin Scale score shift). RESULTS: Among 1600 patients in the trial, 482 had suitable magnetic resonance imaging (mean age, 71 years; 47.1% female). Cortical superficial siderosis burden emerged as the dominant harmful marker: each increment was associated with increased risk of symptomatic ICH (adjusted odds ratio [aOR] per additional affected sulcus, 3.88 [95% CI, 2.87-5.26]), any ICH (aOR, 1.91 [95% CI, 1.22-2.98]), hemorrhage severity, 90-day mortality (aOR, 1.42 [95% CI, 1.18-1.71]), worse modified Rankin Scale scores (adjusted common odds ratio, 1.74 [95% CI, 1.58-1.91]), and lower odds of excellent functional recovery (aOR, 0.70 [95% CI, 0.64-0.77]). Fulfilling probable radiological Boston criteria, versions 1.0 and 1.5, increased odds of any ICH (aOR, 2.57 and 2.39 [95% CI, 2.05-3.23]; aOR, 2.39 [95% CI, 1.71-3.34], respectively), whereas fulfilling possible Boston criteria, version 1.5, was associated with worse modified Rankin Scale scores (adjusted common odds ratio, 2.34 [95% CI, 1.30-4.22]). Boston criteria, version 2.0, were not significantly associated with any hemorrhagic outcomes. CONCLUSIONS: In thrombolyzed patients with acute ischemic stroke, cortical superficial siderosis burden is strongly and consistently associated with higher risk of severe hemorrhage, disability, and death, making it a particularly relevant CAA marker when weighing thrombolytic risk versus benefit. Meeting radiological Boston criteria, versions 1.0 or 1.5, increases hemorrhagic risk, but meeting the latest 2.0 criteria does not.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Marzoughi S, Alhabli I, Singh N, et al. Cerebral Amyloid Angiopathy Imaging Markers, Radiological Boston Criteria, and Thrombolysis Outcomes in Ischemic Stroke. Stroke. 2026. PMID: 41608814. doi:10.1161/STROKEAHA.125.054654

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。